Burden of CKD, proteinuria, and cardiovascular risk among Chinese, Mongolian, and Nepalese participants in the international society of nephrology screening programs

American Journal of Kidney Diseases

Volumn 56, Issue 5, 2010, Pages 915-927

  Sharma, Sanjib Kumar ^a   Zou, Hequn ^b   Togtokh, Ariunaa ^c   Ene Iordache, Bogdan ^d   Carminati, Sergio ^d   Remuzzi, Andrea ^d,e   Wiebe, Natasha ^f   Ayyalasomayajula, Bharati ^f   Perico, Norberto ^d   Remuzzi, Giuseppe ^d,g   Tonelli, Marcello ^f,g  

^a BP Koirala Institute of Health Sciences ^*  (Nepal)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c University of Mongolia   (Mongolia)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e UNIVERSITY OF BERGAMO   (Italy)

^f UNIVERSITY OF ALBERTA   (Canada)

^g OSPEDALI RIUNITI   (Italy)

Author keywords

Chronic disease; chronic kidney disease; Index Words; low income countries; screening

Indexed keywords

C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CHINA; CHINESE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL PROTOCOL; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEASIBILITY STUDY; FEMALE; GENERAL PRACTITIONER; GLOMERULUS FILTRATION RATE; HEALTH PROGRAM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MONGOLIA; NEPAL; OBESITY; PREVALENCE; PROTEINURIA; RISK FACTOR; SCREENING; SYSTOLIC BLOOD PRESSURE; URINALYSIS; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; KIDNEY FAILURE, CHRONIC; MASS SCREENING; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; PROGRAM EVALUATION; PROSPECTIVE STUDY;

ADULT; CARDIOVASCULAR DISEASES; CHINA; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MASS SCREENING; MIDDLE AGED; MONGOLIA; NEPAL; PROGRAM EVALUATION; PROSPECTIVE STUDIES; PROTEINURIA; SOCIETIES, MEDICAL;

EID: 77958451512     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.06.022     Document Type: Article

References (25)

1. A.D. Lopez, C.D. Mathers, M. Ezzati, D.T. Jamison, and C.J. Murray Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data Lancet 367 2006 1747 1757
2. R. Beaglehole, and D. Yach Globalisation and the prevention and control of non-communicable disease: the neglected chronic diseases of adults Lancet 362 2003 903 908
3. L. Quam, R. Smith, and D. Yach Rising to the global challenge of the chronic disease epidemic Lancet 368 2006 1221 1223
4. D. Yach, C. Hawkes, C.L. Gould, and K.J. Hofman The global burden of chronic diseases: overcoming impediments to prevention and control JAMA 291 2004 2616 2622
5. M.P. Hossain, E.C. Goyder, J.E. Rigby, and M. El Nahas CKD and poverty: a growing global challenge Am J Kidney Dis 53 2009 166 174
6. A.S. Levey, A.C. Schoolwerth, and N.R. Burrows Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention Am J Kidney Dis 53 2009 522 535
7. A.V. Chobanian, G.L. Bakris, and H.R. Black The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560 2571
8. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease Am J Kidney Dis 39 suppl 1 2002 S76 S110
9. Y.C. Ma, L. Zuo, and J.H. Chen Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease J Am Soc Nephrol 17 2006 2937 2944
10. World Health Organization Obesity: Preventing and Managing the Global Epidemic Technical Report Series No 894 2000 World Health Organization Geneva, Switzerland
11. T.A. Gaziano, C.R. Young, G. Fitzmaurice, S. Atwood, and J.M. Gaziano Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort Lancet 371 2008 923 931
12. J.M. Gutierrez-Padilla, M. Mendoza-Garcia, and S. Plascencia-Perez Screening for CKD and cardiovascular disease risk factors using mobile clinics in Jalisco, Mexico Am J Kidney Dis 55 2010 474 484
13. M.K. Mani Experience with prevention programs in the Asian Pacific region Kidney Int Suppl 67 2005 S75 S78
14. W.E. Hoy, Z. Wang, and P. VanBuynder The natural history of renal disease in Australian Aborigines Part 2. Albuminuria predicts natural death and renal failure Kidney Int 60 2001 249 256 (Pubitemid 32587561)
15. E.K. Sumaili, J.M. Krzesinski, and C.V. Zinga Prevalence of chronic kidney disease in Kinshasa: results of a pilot study from the Democratic Republic of Congo Nephrol Dial Transplant 24 2009 117 122
16. J.H. Dirks, D. de Zeeuw, and S.K. Agarwal Prevention of chronic kidney and vascular disease: toward global health equitythe Bellagio 2004 Declaration Kidney Int Suppl 98 2005 S1 S6
17. J.H. Dirks, S.W. Robinson, and M. Alderman Meeting report on the Bellagio Conference 'prevention of vascular diseases in the emerging world: an approach to global health equity' Kidney Int 70 2006 1397 1402
18. M.K. Mani Nephrologists sans frontieres: preventing chronic kidney disease on a shoestring Kidney Int 70 2006 821 823
19. S. Klahr, A.S. Levey, and G.J. Beck The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease N Engl J Med 330 1994 877 884 (Pubitemid 24094966)
20. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
21. T.H. Jafar, C.H. Schmid, and M. Landa Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease A meta-analysis of patient-level data Ann Intern Med 135 2001 73 87
22. E.J. Lewis, L.G. Hunsicker, R.P. Bain, and R.D. Rohde The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy N Engl J Med 329 1993 1456 1462
23. S. Bianchi, R. Bigazzi, A. Caiazza, and V.M. Campese A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease Am J Kidney Dis 41 2003 565 570
24. M. Tonelli, L. Moye, F.M. Sacks, T. Cole, and G.C. Curhan Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease J Am Soc Nephrol 14 2003 1605 1613
25. J. Liu, Y. Hong, and R.B. D'Agostino Sr Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study JAMA 291 2004 2591 2599